Stocks and Investing Stocks and Investing
Mon, August 19, 2024
Fri, August 16, 2024

Asthika Goonewardene Maintained (STRO) at Strong Buy with Decreased Target to $15 on, Aug 16th, 2024


Published on 2024-10-28 13:44:03 - WOPRAI, Asthika Goonewardene
  Print publication without navigation


Asthika Goonewardene of Truist Securities, Maintained "Sutro Biopharma, Inc." (STRO) at Strong Buy with Decreased Target from $18 to $15 on, Aug 16th, 2024.

Asthika has made no other calls on STRO in the last 4 months.



There are 4 other peers that have a rating on STRO. Out of the 4 peers that are also analyzing STRO, 0 agree with Asthika's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Asthika


  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $12 on, Wednesday, August 14th, 2024
  • Jay Olson of "Oppenheimer" Maintained at Buy and Held Target at $10 on, Wednesday, May 15th, 2024
  • David Nierengarten of "Wedbush" Reiterated at Buy and Held Target at $8 on, Tuesday, May 14th, 2024
  • Tazeen Ahmad of "B of A Securities" Initiated at Strong Buy and Held Target at $12 on, Wednesday, May 8th, 2024
Contributing Sources